stella
beta
Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome — Stella
Recruiting
Back to Netherton Syndrome trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(4 sites)
United States
Site #1, San Diego, California
Site #4, Indianapolis, Indiana
Site #5, Quincy, Massachusetts
Site #2, San Antonio, Texas
View full record on ClinicalTrials.gov